GDF15 propeptide 通过增强骨微环境,促进割抵抗性前列腺癌的骨转移
Gaku Yamamichi1, Taigo Kato2, Noriaki Arakawa3,4
1Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Biomarker research
|November 26, 2024
概括
增长分化因子15 (GDPP) 是一种新的血液生物标志物,用于割抵抗性前列腺癌 (CRPC) 的骨转移 (BM). GDPP有助于早期检测和治疗CRPC患者的治疗干预措施.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 骨转移 (BM) 是割抵抗性前列腺癌 (CRPC) 的一个重大挑战,缺乏有效的血液生物标志物和明确的潜在机制.
- 目前的CRPC与BM的诊断方法有限,需要识别新的生物标志物以改善患者的预后.
研究的目的:
- 为了确定精确的血液生物标志物来评估CRPC中的BM.
- 调查已识别的生物标志物在CRPC骨转移的进展中的作用.
主要方法:
- 使用Orbitrap质谱仪对前列腺癌细胞系的秘密组分析,以确定分泌的蛋白质.
- 在体外测试检查鉴定蛋白质对癌细胞,骨质母细胞和骨质母细胞的影响.
- 在体内研究使用BM小鼠模型和临床评估CRPC患者的骨光学.
主要成果:
- 鉴定了2,787种蛋白质;由于其由癌细胞和骨细胞分泌,专注于GDF15 (GDPP).
- 在小鼠模型中,GDPP促进了CRPC细胞的增殖,入侵和迁移,并加剧了BM.
- 在CRPC患者中,GDPP在BM的诊断准确度高于PSA和其他生物标志物,并且与治疗反应相关.
结论:
- GDPP增强了BM中的瘤微环境,并作为CRPC中BM的新型血液生物标志物.
- GDPP有可能促进早期治疗干预,改善CRPC患者的治疗结果.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


